Clinical Trial Update: Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy [EARLY_Phase 1]

View source ↗

Summary

Status update on a Phase 1 trial evaluating phenylbutyrate for monogenic developmental and epileptic encephalopathies, including STXBP1-related encephalopathy w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Developmental and Epileptic Encephalopathy
• Slc6a1-related Neurodevelopmental Disorder with Epilepsy
• Stxbp1-related Developmental and Epileptic Encephalopathy

Drugs mentioned

• Phenylbutyrate (phenylbutyrate)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder, Developmental and Epileptic Encephalopathy | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING